Market niche Nascent Surgical focuses on surgical smoke evacuation with the miniSquair device, presenting a specialized entry point in operating room safety. This suggests sales opportunities with hospitals and surgical centers seeking advanced plume control and infection prevention solutions.

SMO infection control Position the miniSquair as an infection control tool in open surgeries, leveraging research indicating its potential to reduce bioaerosol exposure. Target OR managers and infection prevention teams alongside surgeons to expand adoption.

Founder leverage With Dr. Leonard Schultz’s track record of smoke evacuation innovations and multiple patents, emphasize product credibility and innovation leadership when engaging prospects in procurement discussions and competitive comparisons.

Growth opportunities Revenue is under one million with modest funding; align outreach to mid to large surgical centers and networks that can scale adoption, and explore partnerships or pilot programs to demonstrate ROI and liability risk reduction.

Competitive fit Benchmark against broader surgical smoke and infection control players by highlighting miniSquair’s 99.5% bioaerosol capture rate, and pursue opportunities within hospitals already using major players but open to specialized, higher-performance solutions.